[Form 4] CaliberCos Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 snapshot – CaliberCos Inc. (CWD)

Director Lawrence X. Taylor III reported an option grant on 17 June 2025 under the company’s 2024 Equity Incentive Plan. The filing discloses the acquisition of 5,052 employee stock options with an exercise price of $3.55 per share and an expiration date of 17 June 2035. The options were acquired as part of normal board compensation; no shares were sold.

Following the transaction, Taylor directly holds 14,821 derivative securities linked to CWD Class A common stock. No non-derivative share transactions were reported. The filing does not reference any Rule 10b5-1 trading plan and does not alter Taylor’s status as a company director.

Because the transaction is a routine equity incentive grant with a modest size relative to CaliberCos’ public float, market impact is expected to be immaterial.

Insights

Financial Analyst

TL;DR: Routine director option grant; no shares sold; negligible valuation impact.

The 5,052 options granted to Director Lawrence X. Taylor III at $3.55 strike are standard board compensation under the 2024 plan. Post-grant derivative holdings rise to 14,821, but there is no cash outlay by the company today and no immediate dilution because the options are unexercised. Absence of share sales or insider selling signals means the transaction carries neutral sentiment. Given CaliberCos’ small capitalization, even full exercise would likely represent <1% of current shares outstanding, so valuation effect is minimal.

Corporate Governance Specialist

TL;DR: Grant aligns with normal director pay; compliant disclosure; neutral governance impact.

The options were issued pursuant to an approved equity plan, satisfy Section 16 reporting within the two-business-day window, and include all mandated details (strike, term, quantity). The filing contains no red flags such as back-dating, accelerated vesting, or insider selling. Therefore, from a governance standpoint, the event is routine and not materially impactful to shareholder rights or board independence.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Lawrence X. III

(Last) (First) (Middle)

8901 E MOUNTAIN VIEW RD

#150

(Street)

SCOTTSDALE AZ 85258

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CaliberCos Inc. [ CWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (right to buy)(1)	$3.55	06/17/2025		A		5,052		06/17/2025	06/17/2035	Class A Common Stock	5,052	(2)	14,821	D

Explanation of Responses:

1. Employee Stock Options (right to buy)("Options") granted pursuant to Issuer's 2024 Equity Incentive Plan. Such Options represent a portion of Reporting Person's compensation as a director of Issuer.

2. Not applicable

Remarks:

	/s/ Lawrence X. Taylor III	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many options did Director Lawrence X. Taylor III receive from CaliberCos (CWD)?

5,052 employee stock options were granted on 17 June 2025.

What is the exercise price of the newly granted CWD options?

The options carry a $3.55 per-share exercise price.

Did the director sell any CaliberCos shares in this Form 4 filing?

No. The filing reports only an acquisition of options; no shares were sold.

What is the expiration date of the granted options?

The options expire on 17 June 2035.

How many derivative securities does the director hold after this grant?

Post-transaction, Taylor beneficially owns 14,821 options directly.